Saliva as a diagnostic matrix for drug abuse

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 3, 2005, Pages 567-573

  Lo Muzio, Lorenzo ^a,d   Falaschini, S ^b   Rappelli, G ^b   Bambini, F ^b   Baldoni, A ^c   Procaccini, M ^b   Cingolani, M ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Local Health Service Section No 7   (Italy)

^d NONE   (Italy)

Author keywords

Drug abuse; Immunological test; Saliva

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABIS; METHADONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANALYTIC METHOD; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG ABUSE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOLOGICAL TECHNIQUE; INFORMATION PROCESSING; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SALIVA ANALYSIS; SCREENING TEST; VALIDATION PROCESS;

EID: 27444437262     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800317     Document Type: Article

References (22)

1. Kaufman E. and I.B. Lamster. 2002. The diagnostic applications of saliva- a review. Crit. Rev. Oral Biol. Med. 13:197.
2. Tavassoli M., N. Brunel, R. Maher, N.W. Johnson and T. Soussi. 1998. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int. J. Cancer 78:390.
3. Streckfus C., L. Bigler, M. Tucci and J.T. Thigpen. 2000. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 18:101.
4. Chien D.X. and P.E. Schwartz. 1990. Saliva and serum CA125 assays for detecting malignant ovarian tumors. Obstet. Gynecol. 75:701.
5. Archibald D.W., J.J. Farley, Jr., C.A. Hebert, S.E. Hines, P. Nair and J.P. Johnson. 1993. Practical applications for saliva in perinatal HIV diagnosis. Ann. N.Y. Acad. Sci. 694:195.
6. Li C., T. Ha, D.A. Jr. Ferguson, D.S. Chi, R. Zhao, N.R. Patel, G. Krishnaswamy and E. Thomas. 1996. A newly developed PCR assay of H. pylori in gastric biopsy, saliva, and feces. Evidence of high prevalence of H. pylori in saliva supports oral transmission. Dig. Dis. Sci. 41:2142.
7. Thieme T., P. Yoshihara, S. Piacentini and M. Beller. 1992. Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis. J. Clin. Microbiol 30:1076.
8. Kankirawatana P. 1999. Salivary antiepileptic drug levels in Thai children. J. Med. Assoc. Thai. 82:80.
9. 125I-labeled cyclosporine. Clin. Chem. 34:1545.
10. Takahashi T., Y. Fujiwara, H. Sumiyoshi, T. Isobe, N. Yamaoka and M. Yamakido. 1997. Salivary drug monitoring of irinotecan and its active metabolite in cancer patients. Cancer Chemother. Pharmacol. 40:449.
11. Gorodetzky C.W. and M.P. Kullberg. 1974. Validity of screening methods for drugs of abuse in biological fluids. Clin. Pharmacol. Ther. 15:579.
12. Kang G.I. and F.S. Abbott. 1982. Analysis of methadone and metabolites in biological fluids with gas chromatography-mass spectrometry. J. Chromatogr. 231:311.
13. Cone E.J., K. Kumor, L.K. Thompson and M. Sherer. 1988. Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J. Anal. Toxicol. 12:200.
14. Wan S.H., S.B. Matin and D.L. Azarnoff. 1978 Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH. Clin. Pharmacol. Ther. 23:585.
15. DiGregorio G.J., A.J. Piraino and E. Ruch. 1978. Diazepam concentrations in parotid saliva, mixed saliva, and plasma. Clin. Pharmacol. Then 24:720.
16. Van der Graaff M., N.P. Vermeulen, P. Heij, J.K. Boeijinga and D.D. Breimer. 1986. Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects. Biopharm. Drug Dispos. 7:265.
17. McCarron M.M., C.B. Walberg, J.R. Soares, S.J. Gross and R.C. Baselt. 1984. Detection of phencyclidine usage by radioimmunoassay of saliva. J. Anal. Toxicol. 8:197.
18. Hawks R.L. 1982. The constituents of cannabis and the disposition and metabolism of cannabinoids. Natl. Inst. Drug Abuse Res. Monogr. Ser. 42:125.
19. Cingolani M., M. Cippitelli, R. Froldi, V. Gambaro and G. Tassoni. 2004. Detection and quantitation analysis of cocaine and metabolites in fixed liver tissue and formalin solutions. J. Anal. Toxicol. 28:16.
20. Phillips J.E., S. Bogema, P. Fu, W. Furmaga, A.H. Wu, V. Zic and C. Hammett-Stabler. 2003. Signify(R) ER Drug Screen Test evaluation: comparison to Triage(R) Drug of Abuse Panel plus tricyclic antidepressants. Clin. Chim. Acta 328:31.
21. Jenkins A.J., W.D. Darwin, M.A. Huestis, E.J. Cone and J.M. Mitchell. 1995. Validity testing of the accuPINCH THC test. J. Anal. Toxicol. 19:5.
22. Moriya F. and Y. Hashimoto. 1996. Application of the Triage panel for drugs of abuse to forensic blood samples. Nippon Hoigaku Zasshi 50:50.